Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

JPT Peptide Technologies

JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products & kits, as well as a research and development partner for projects in Immunotherapy, Immunology, Proteomics and Drug Discovery.
JPT is ISO 9001 certified and takes pride in its excellent customer support.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group logo

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Market access, Regulatory affairs, Research and development

Company Details

JPT Peptide Technologies
Volmerstr. 5, Berlin, 12489, Germany
Contact JPT Peptide Technologies
Website

 Latest Content from PMHub 

Gene Editing and Precision Medicine: The Future of Healthcare?

Videos and Podcasts | March 4, 2021 | Impetus Digital

Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,...

CRM Design and Optimization for Life Science Organizations

Videos and Podcasts | March 4, 2021 | Impetus Digital

John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical...

Andi Goes – the children’s book that helps detect early signs of dyslexia

Press Releases | March 3, 2021 | Havas Lynx

Havas Lynx Group have launched a children’s book aimed at raising awareness and detecting early signs of dyslexia. Helping to make sure that parents have the support they need whilst...

The imperfect art of sustainable communications

Press Releases | March 2, 2021 | 11 London

Scanning the papers this last week, we’ve seen a welcome departure from wall-to-wall gloom –and very real signs of ‘Reasons To Be Cheerful’.The economy, we’re told, might not be such...

Good design saves lives

White Papers and Resources | March 2, 2021 | Page & Page Health

Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...

Licensing Deal for NP213 Nail Fungus Treatment is Another Key Milestone for NovaBiotics

Press Releases | March 1, 2021 | Onyx Health

Leading biotechnology company NovaBiotics Ltd have secured a major licensing deal for their fungal nail treatment

Rare Disease Day in a COVID-19 environment

Press Releases | February 28, 2021 | Lucid Group Communications Limited

For many people and families living with a rare disease, their journey can be very complex. At times, that journey can even be scary, frustrating and confusing. However, when your...

Bedrock’s strong start to 2021

Press Releases | February 26, 2021 | Bedrock Healthcare Communications

Just two months into the year and at Bedrock we’ve already added FOUR new people to an ever-growing team!

Enabling Patient-Focused Research Through Virtual Clinical Trials

Videos and Podcasts | February 25, 2021 | Impetus Digital

Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital...

Innovative Approaches to Managing Mental Health Conditions

Videos and Podcasts | February 25, 2021 | Impetus Digital

Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and...